INTELLIGENT BIO SOLUTIONS INC. — Director's Dealing 2020

Dec 30, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GBS Inc. (GBS)
CIK: 0001725430
Period of Report: 2020-12-22

Reporting Person: Sakiris Spiro Kevin (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, par value $0.01 per share	300	Direct
Common stock, par value $0.01 per share	1479	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Convertible Preferred Stock	$		Common Stock (3000)		Direct
Series A Warrant	$		Common Stock (1479)		Direct
Series B Warrant	$		Common Stock (1479)		Direct
Common Stock Purchase Warrant	$		Common Stock (3000)		Direct

Footnotes

F1: The Series A Convertible Preferred Stock (the "Series A Stock") is automatically convertible into 3,000 shares of the Company's common stock at the closing of the Company's initial public offering (the "IPO") that took place on December 28, 2020.

F2: Includes Series A warrant to purchase 1,479 shares of the Company's common stock at an exercise price equal to $8.50 per share exercisable until the fifth anniversary of the issuance date.

F3: Includes Series B warrant to purchase 1,479 shares of the Company's common stock and together with the Series A Warrants at an exercise price equal to $17.00 per share, exercisable until the fifth anniversary of the issuance date and subject to certain adjustment and cashless exercise provisions as described herein.

F4: Includes warrants to purchase 3,000 shares of the Company's common stock exercisable during the one year-period commencing on the 2nd anniversary of the closing of the IPO at exercise price of $8.50 per share. The warrant expiration date is December 28, 2023.